Maravai LifeSciences
MRVI
6.98
-0.21
-2.92%
Maravai LifeSciences
US · MRVI
#3116 by market cap
Listed 2020
6.98
-0.21
-2.92%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Deutsche Bank Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $6Market Newswire · 2026/5/8
-
Rating change
Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy RatingMarket Newswire · 2026/9/16
-
Rating change
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $4Market Newswire · 2026/2/28
-
Rating change
William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold RatingMarket Newswire · 2026/8/7
-
Rating change
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $4Market Newswire · 2025/11/8
-
Rating change
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $6Market Newswire · 2026/5/12
-
Rating change
Wells Fargo Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $4Market Newswire · 2025/8/13
-
Rating change
Guggenheim Maintains Maravai LifeSciences(MRVI.US) With Hold RatingMarket Newswire · 2026/5/11
-
Rating change
Wells Fargo Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $4.5Market Newswire · 2025/12/15
-
Rating change
A Quick Look at Today's Ratings for Maravai LifeSciences(MRVI.US), With a Forecast Between $5 to $5Market Newswire · 2025/8/12
-
KeyBanc Initiates Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $11Market Newswire · 2026/11/12
-
Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $10Market Newswire · 2026/11/5
-
Rating change
Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $5Market Newswire · 2026/5/8
-
Rating change
Morgan Stanley Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Maintains Target Price $5Market Newswire · 2025/5/22
-
TD Cowen Initiates Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $9Market Newswire · 2026/10/5
-
Earnings Flash (MRVI) Maravai LifeSciences Holdings, Inc. Posts Q3 Adjusted Loss $0.03 per Share, Vs. FactSet Est of $-0.06MT Newswires · 2026/11/5
-
Rating change
William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Announces Target Price $3.94Market Newswire · 2026/5/8
-
Rating change
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $5Market Newswire · 2025/8/13
-
Rating change
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $8Market Newswire · 2026/8/13
-
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $9.5Market Newswire · 2026/11/5
-
Rating change
UBS Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Cuts Target Price to $2.5Market Newswire · 2025/3/22
-
Rating change
Morgan Stanley Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Cuts Target Price to $5Market Newswire · 2025/3/25
-
Rating change
RBC Capital Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $7Market Newswire · 2025/4/10
-
Rating change
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $5Market Newswire · 2025/3/22
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Maravai LifeSciences discussion 0 comments